Rekah Pharmaceutical Industry Ltd (REKA) — Defensive Interval Ratio
Rekah Pharmaceutical Industry Ltd (REKA) has a Defensive Interval Ratio of 298 days as of June 2026. Defensive assets of ILA141.34 Million (cash ILA-, short-term investments ILA39.00K, receivables ILA141.31 Million) cover 298 days of daily cash needs of ILA474.77K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Rekah Pharmaceutical Industry Ltd Defensive Interval Ratio (2004–2025)
This chart shows how Rekah Pharmaceutical Industry Ltd's Defensive Interval Ratio has evolved across 22 annual periods from 2004 to 2025. As of June 2026, the ratio stands at 298 days, meaning defensive assets of ILA141.34 Million can fund 298 days of operations without new revenue. For the complete balance sheet picture, see REKA total assets.
Annual Defensive Interval Ratio for Rekah Pharmaceutical Industry Ltd (2004–2025)
The table below presents the year-by-year Defensive Interval Ratio for Rekah Pharmaceutical Industry Ltd from 2004 to 2025, covering 22 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Rekah Pharmaceutical Industry Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (ILA) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 307 days | ILA127.63 Million | ILA416.07K/day | ILA- | ILA39.00K | ▲ +8 days |
| 2024 | 299 days | ILA129.39 Million | ILA432.99K/day | ILA- | ILA39.00K | ▲ +0 days |
| 2023 | 299 days | ILA117.72 Million | ILA393.93K/day | ILA- | ILA39.00K | ▼ -18 days |
| 2022 | 317 days | ILA120.79 Million | ILA380.90K/day | ILA- | ILA80.00K | ▼ -80 days |
| 2021 | 398 days | ILA107.41 Million | ILA270.17K/day | ILA- | ILA39.00K | ▲ +102 days |
| 2020 | 296 days | ILA87.67 Million | ILA296.60K/day | ILA- | ILA40.00K | ▼ -42 days |
| 2019 | 338 days | ILA78.32 Million | ILA232.01K/day | ILA- | ILA40.00K | ▼ -5 days |
| 2018 | 342 days | ILA74.84 Million | ILA218.76K/day | ILA- | ILA43.00K | ▼ -53 days |
| 2017 | 396 days | ILA84.49 Million | ILA213.61K/day | ILA- | ILA29.00K | ▲ +28 days |
| 2016 | 367 days | ILA93.68 Million | ILA255.18K/day | ILA- | ILA1.78 Million | ▼ -51 days |
| 2015 | 418 days | ILA105.97 Million | ILA253.28K/day | ILA- | ILA1.75 Million | ▲ +124 days |
| 2014 | 295 days | ILA106.29 Million | ILA360.78K/day | ILA- | ILA4.30 Million | ▲ +118 days |
| 2013 | 177 days | ILA97.74 Million | ILA552.54K/day | ILA- | ILA5.22 Million | ▼ -6 days |
| 2012 | 183 days | ILA98.47 Million | ILA538.87K/day | ILA- | ILA3.38 Million | ▼ -28 days |
| 2011 | 211 days | ILA97.05 Million | ILA460.67K/day | ILA- | ILA9.22 Million | ▼ -37 days |
| 2010 | 247 days | ILA103.99 Million | ILA420.26K/day | ILA- | ILA18.76 Million | ▼ -46 days |
| 2009 | 294 days | ILA107.22 Million | ILA364.86K/day | ILA- | ILA24.34 Million | ▼ -71 days |
| 2008 | 365 days | ILA114.02 Million | ILA312.77K/day | ILA- | ILA26.70 Million | ▼ -13 days |
| 2007 | 377 days | ILA124.29 Million | ILA329.34K/day | ILA- | ILA35.68 Million | ▲ +28 days |
| 2006 | 350 days | ILA117.66 Million | ILA336.35K/day | ILA- | ILA32.45 Million | ▼ -51 days |
| 2005 | 401 days | ILA106.19 Million | ILA265.08K/day | ILA- | ILA37.18 Million | ▲ +150 days |
| 2004 | 250 days | ILA65.78 Million | ILA262.99K/day | ILA- | ILA- | — |